Abstract
Competitive CB1 receptor antagonists carrying an aromatic SF5 group in position 3 of a pyrazole ring were synthesised and compared with their CF3 and tert-butyl analogues. Results confirmed that an aromatic SF5 group can be used as a bioisosteric analogue of a CF3 group and possibly of a bulky aliphatic group too.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.